1. Ahlberg A. Radioactive gold in the treatment of chronic synovial effusion in hemophilia. In: Ana F, Denson R, editors. Hemophilia. Proc. VII Congress World Federation of Hemophilia. Amsterdam, Holland, Teherat Excerpta Medica; 1971. pp. 212-215
2. Barboza MF, Casiglia MT, Souza AA, Herrerias R, Bambalas E, Santos C, Alves J, Osso JA Jr, Calegaro JUM. 153Sm-HA: Radiopharmaceutical agent for synovectomy. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 2006;50(Suppl 1):46-47
3. Calegaro JU, Machado J, de Paula JC, de Almeida JSC, Casulari LA. Clinical evaluation after 1 year of 153-samarium hydroxyapatite synovectomy in patients with haemophilic arthropathy. Haemophilia. 2009;15:240-246
4. Calegaro JUM, Machado J, Furtado RG, de Almeida JSC, de Vasconcelos AVP, Barboza MF, de Paula AP. The use of 185 MBq and 740 MBq of 153-samarium hydroxyapatite for knee synovectomy in haemophilia. Haemophilia. 2014;20:421-425
5. Calegaro J, Silveira C, Hage D, Sayago M, de Landa D, Mengatti J, de Paula AP. Comparison of the effect of knee synovectomy in haemophilic patients with 153Sm- and 90Y-labelled hydroxyapatite 1 year after. Haemophilia. 2014;20:873-878